Recursion Pharmaceuticals Needs A Clinical Breakthrough To Pique Interest
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Business Insider21d
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Recursion will also hold a webinar on Thursday, February 6th at 6:30am MT/8:30am ET/1:30pm GMT to present the Phase 2 data. The webinar will be broadcast from Recursion’s X (formerly Twitter ...
pharmaphorum1d
Recursion, Exscientia, and AI drug discovery’s moment of truth
In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.
NDTV8d
Putin, Trump Want To Head Past "Abnormal Relations": Russian Foreign Minister
In a phone call last week, "Putin and Trump agreed on the necessity of leaving behind absolutely abnormal relations," Sergei Lavrov said, adding that "the presidents agreed dialogue needs to be ...
The Hill7d
5 things to know about US-Russia talks on Ukraine
Secretary of State Marco Rubio’s meeting with his Russian counterpart in Riyadh on Tuesday marked a major shift in U.S. relations with the country, ending a policy of isolation imposed after ...
Cfr.org29d
The Fall of Goma
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Once again, the eastern Congolese city of Goma has fallen to the Rwanda-backed ...
The Advocate29d
Mike McCarthy makes surprising decision in relation to Saints coaching search
McCarthy's decision to remove himself from the process is another blow to the Saints' coaching search, which has seen several candidates withdraw from the process or accept another job.
pharmaphorum1d
AI biotechs Exscientia and Recursion agree $688m merger
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Newsweek3d
Are You Stuck in a 'Roommate Relationship'? 6 Signs to Look for
Research indicates that relationship satisfaction tends to decrease between the ages of 20 and 40, reaching a low point around age 40. This period often coincides with when relationships have ...
Euronews8d
EU-US trade relations shouldn't impact probes on Big Tech, lead lawmaker says
explaining that the EU shouldn’t take into account its trade relations with the US when deciding on DMA probes on Big Tech. In the midst of Donald Trump's trade offensive against the EU ...
Cfr.org28d
Who Controls the Panama Canal?
Today, many experts see the treaties as having heralded a new era of U.S.-Latin America relations. Panamanian President José Raúl Mulino swiftly rebuked Trump’s comments, asserting that ...